S. 445 · 109th Congress
Medicare Prescription Drug Price Reduction Act of 2005
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 109th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
StabenowSponsor11 cosponsors · 11 D
D
Bingaman
TC
D
Carper
TJ
D
Johnson
TK
D
Kennedy
CS
D
Schumer
BB
D
Boxer
MC
D
Cantwell
HK
D
Kohl
TH
D
Harkin
BM
D
Mikulski
PL
D
Leahy5 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Medicare Prescription Drug Price Reduction Act of 2005 - Amends title XVIII (Medicare) of the Social Security Act to repeal provisions prohibiting the Secretary of Health and Human Services from: (1) interfering with the negotiations between drug manufacturers and pharmacies and prescription drug plan sponsors; and (2) requiring a particular formulary to…
What it does: CRS summary · Introduced in Senate · Feb 17, 2005
Medicare Prescription Drug Price Reduction Act of 2005 - Amends title XVIII (Medicare) of the Social Security Act to repeal provisions prohibiting the Secretary of Health and Human Services from: (1) interfering with the negotiations between drug manufacturers and pharmacies and prescription drug plan sponsors; and (2) requiring a particular formulary to institute a price structure for the reimbursement of covered Medicare part D (Voluntary Prescription Drug Benefit Program) drugs.
Grants the Secretary instead, in order to ensure that each part D eligible individual who is enrolled under a prescription drug plan or a Medicare Advantage prescription drug plan pays the lowest possible price, authority similar to that of other Federal entities that purchase prescription drugs in bulk to negotiate contracts with manufacturers of covered Medicare part D drugs, consistent with the requirements and in furtherance of the goals of providing quality care and containing costs under such part.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Medicare Prescription Drug Price Reduction Act of 2005
Latest action (Feb 17, 2005): Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S1659)
Policy area: Health · Origin: Senate · Introduced: Feb 17, 2005
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.